Gregory Deener
Vertrieb & Marketing bei Sucampo Pharma Americas LLC
Aktive Positionen von Gregory Deener
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sucampo Pharma Americas LLC | Vertrieb & Marketing | - | - |
Karriereverlauf von Gregory Deener
Ehemalige bekannte Positionen von Gregory Deener
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Vertrieb & Marketing | 01.02.2004 | 01.06.2011 |
GlaxoSmithKline North Carolina
GlaxoSmithKline North Carolina Pharmaceuticals: OtherHealth Technology Part of GSK Plc, GlaxoSmithKline North Carolina is a company that develops, manufactures, and markets vaccines and other pharmaceuticals. The company is based in Durham, NC. | Vertrieb & Marketing | 01.01.1996 | 01.12.2003 |
SUCAMPO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 20.09.2011 | - |
Ausbildung von Gregory Deener
The University of North Carolina at Charlotte | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Sales & Marketing | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
GlaxoSmithKline North Carolina
GlaxoSmithKline North Carolina Pharmaceuticals: OtherHealth Technology Part of GSK Plc, GlaxoSmithKline North Carolina is a company that develops, manufactures, and markets vaccines and other pharmaceuticals. The company is based in Durham, NC. | Health Technology |
Sucampo Pharma Americas LLC |
- Börse
- Insiders
- Gregory Deener
- Erfahrung